Velocity Clinical Research, Inc.

Day 10 of The 12 Days of Velocity highlights our exciting expansion into Latin America, a region representing 10% of the world’s clinical research sites and home to key markets like Brazil, Argentina, and Mexico.   We’re thrilled to welcome Renata Berardocco as Executive Vice President and Managing Director for Latin America (LATAM). With nearly 20 years of leadership experience at Fortrea, Novartis, and Stiefel (GSK), Renata is the perfect leader to spearhead our growth in this vibrant and critical region.   As Velocity brings its innovative model to LATAM, we’re focused on creating significant benefits for patients, Sponsors, and CROs—furthering our mission to advance clinical trials globally.   Read more about Renata’s appointment and our LATAM expansion via The Associated Press: https://lnkd.in/gdQeUm9H   #12DaysOfVelocity #LATAM #ClinicalResearch #GlobalExpansion #ClinicalTrials

Day 9 of The 12 Days of Velocity shines a spotlight on the launch of six CARE Councils and our experts who are redefining specialty research across Velocity’s network. These councils bring together experienced physicians, veteran clinicians, and operational experts to: - Discuss scientific trends and review protocols. - Refine best practices to enhance trial conduct across all sites. - Ensure specialty populations are reached with an authentic, informed touch. This year, we launched: - Cardiometabolic CARE Council - CNS CARE Council - Diabetes and Obesity CARE Council - MASH CARE Council - Vaccine CARE Council - Women’s Health CARE Council Learn more about our CARE Councils: https://buff.ly/3VOPb6B #12DaysOfVelocity #CARECouncils #SpecialtyResearch #ClinicalResearch #Innovation

Day 8 of The 12 Days of Velocity is all about growth and progress to better serve our patients, clients, and communities worldwide. This year, we’ve achieved: - 7 site expansion or renovation projects - 9 new sites added to our integrated organization - 10 site moves to larger, more accessible locations - 17 sites across Europe, broadening our global reach As we expand, we’re creating more opportunities for patients to access clinical trials and for Sponsors and CROs to benefit from high-performing, state-of-the-art research sites working at scale. #12DaysOfVelocity #ClinicalResearch #Growth #SiteExpansion #MovinOnUp

Dennis Tsang, MD, a PI at our Huntington Park, CA site, shares how PIVOT and the collaborative environment at Velocity have shaped his experience: - “Clinical research is highly collaborative… Velocity empowers investigators to focus on quality research.” - “Onboarding was seamless… I was quickly up to speed with the latest SOPs and required training.” - “There is a lot of support provided compared to conducting research on your own.” Watch the video to hear more from Dr. Tsang, and learn about our approach to PI development at https://lnkd.in/gknYWZGH. #ClinicalResearch #PITraining #PIVOT #Collaboration #InnovationInResearch

Day 7 of The 12 Days of Velocity celebrates a proud achievement: Velocity was awarded the 2024 Vaccine Industry Excellence (ViE) Award for Best Clinical Trial Company!   This recognition highlights our performance, diverse vaccine trial capabilities, and groundbreaking initiatives that are advancing vaccine research worldwide. Key achievements this year include:  - VISION: Our AI-enabled technology suite contributing to 7,000+ randomizations, including many in vaccine trials.  - In-house lab capabilities: 100% in-network PBMC processing across 30+ locations in the U.S. and Europe.  - Vaccine CARE Council: Providing world-class operational, recruitment, and trial oversight for infectious disease studies.  - Supporting trials that have led to 8 vaccine approvals in the U.S. over within the last two years.   #12DaysOfVelocity #VaccineResearch #ViEAwards #ClinicalExcellence #Innovation

Day 6 of The 12 Days of Velocity celebrates Brandon Essink, MD, CPI, and the launch of our Principal Investigator Onboarding and Training (PIVOT) Program earlier this year, a groundbreaking initiative bridging the gap between Sponsors in need of qualified PIs and physicians seeking research opportunities.   Through mentorship, immersive training, and hands-on experience, PIVOT equips physicians with the skills to excel as PIs. This ensures:  - A roster of reliable, research-ready PIs.  - Exceptional patient care and quality results for Sponsors.  - Greater development and mentorship opportunities for PIs.   See how we're supporting physicians in research: https://lnkd.in/gS6h2QJy   #12DaysOfVelocity #PIVOTProgram #ClinicalResearch #PrincipalInvestigators

Day 5 of The 12 Days of Velocity spotlights VISION, our proprietary, AI-enabled technology platform that’s transforming clinical trial recruitment and participant engagement worldwide.    This year, VISION has:  - Contributed to 7,500+ randomizations, helping connect the right patients to the right trials.  - Made over $5.2 million in in-app participant stipend payments worldwide.  - Achieved 100,000+ downloads globally. By streamlining recruitment efforts and improving the patient experience, VISION is making trials more efficient and accessible. Learn more about our VISION platform: https://lnkd.in/gpZECMhS   #12DaysOfVelocity #ClinicalResearch #AIInnovation #ParticipantEngagement #VISIONTechnology

Day 4 of The 12 Days of Velocity celebrates a remarkable achievement: Velocity has topped Business North Carolina’s Fast 40 list for the third time! But what’s driving this rapid growth? In this article, Paul Evans shares how Velocity’s expansion is transforming clinical trials: - Enhancing patient recruitment and driving inclusivity. - Pioneering advanced AI tools for better trial outcomes. - Scaling with purpose to benefit communities globally. Our growth isn’t just about being fast — it’s about being impactful. Read Paul’s article to discover how Velocity is scaling with purpose: https://lnkd.in/g5f3Yf-7 #12DaysOfVelocity #Fast40 #ClinicalResearch #PurposeDrivenGrowth #Innovation

For Day 3 of The 12 Days of Velocity, we’re celebrating Raghu Punnamraju, Chief Technology Officer, and our team in Hyderabad for advancing tech's role in clinical research. This year, Raghu was featured in two prominent tech publications. In The Mainstream formerly known as CIO News, Raghu discussed “How to Create a Commercially-Minded Tech Team” — a guide to aligning tech development with business objectives. Read the full article here: https://lnkd.in/gRUp7gBq In VentureBeat, he explored “Why Data Science Alone Won’t Make Your Product Successful”, highlighting the importance of collaboration between data and business teams. Read the piece here: https://lnkd.in/gvzBDtDM #12DaysOfVelocity #ClinicalResearch #ClinicalTrials

As an example of Velocity working at scale, 25 of our sites across the U.S., Germany, and U.K. delivered 1,474 participants, which was 137.8% of the initial enrollment goal. Moreover, Velocity: - Filled an allotted U.S. cohort in 2 weeks - Filled a second, invite-only cohort of ages >65 in 1 week - Over-enrolled in Germany in 1 month - Achieved a low 4.2% screen fail rate Ready to leverage Velocity at scale? Let’s talk about your trial: https://lnkd.in/gim_wGVh